Synopsis
0
CEP/COS
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
13
PharmaCompass offers a list of Ferric Carboxymaltose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ferric Carboxymaltose manufacturer or Ferric Carboxymaltose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ferric Carboxymaltose manufacturer or Ferric Carboxymaltose supplier.
PharmaCompass also assists you with knowing the Ferric Carboxymaltose API Price utilized in the formulation of products. Ferric Carboxymaltose API Price is not always fixed or binding as the Ferric Carboxymaltose Price is obtained through a variety of data sources. The Ferric Carboxymaltose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Injectafer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Injectafer, including repackagers and relabelers. The FDA regulates Injectafer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Injectafer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Injectafer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Injectafer supplier is an individual or a company that provides Injectafer active pharmaceutical ingredient (API) or Injectafer finished formulations upon request. The Injectafer suppliers may include Injectafer API manufacturers, exporters, distributors and traders.
click here to find a list of Injectafer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Injectafer DMF (Drug Master File) is a document detailing the whole manufacturing process of Injectafer active pharmaceutical ingredient (API) in detail. Different forms of Injectafer DMFs exist exist since differing nations have different regulations, such as Injectafer USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Injectafer DMF submitted to regulatory agencies in the US is known as a USDMF. Injectafer USDMF includes data on Injectafer's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Injectafer USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Injectafer suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Injectafer Drug Master File in Japan (Injectafer JDMF) empowers Injectafer API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Injectafer JDMF during the approval evaluation for pharmaceutical products. At the time of Injectafer JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Injectafer suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Injectafer Drug Master File in Korea (Injectafer KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Injectafer. The MFDS reviews the Injectafer KDMF as part of the drug registration process and uses the information provided in the Injectafer KDMF to evaluate the safety and efficacy of the drug.
After submitting a Injectafer KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Injectafer API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Injectafer suppliers with KDMF on PharmaCompass.
A Injectafer written confirmation (Injectafer WC) is an official document issued by a regulatory agency to a Injectafer manufacturer, verifying that the manufacturing facility of a Injectafer active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Injectafer APIs or Injectafer finished pharmaceutical products to another nation, regulatory agencies frequently require a Injectafer WC (written confirmation) as part of the regulatory process.
click here to find a list of Injectafer suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Injectafer as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Injectafer API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Injectafer as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Injectafer and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Injectafer NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Injectafer suppliers with NDC on PharmaCompass.
Injectafer Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Injectafer GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Injectafer GMP manufacturer or Injectafer GMP API supplier for your needs.
A Injectafer CoA (Certificate of Analysis) is a formal document that attests to Injectafer's compliance with Injectafer specifications and serves as a tool for batch-level quality control.
Injectafer CoA mostly includes findings from lab analyses of a specific batch. For each Injectafer CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Injectafer may be tested according to a variety of international standards, such as European Pharmacopoeia (Injectafer EP), Injectafer JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Injectafer USP).
